Indications
Adjunct to general anesthesia, to facilitate endotracheal intubation and to provide muscle relaxation during surgery or mechanical ventilation.
Contraindications
Known hypersensitivity to vecuronium.
Adult dose
Intubation: 0.08-0.1 mg/kg IV bolus. Good or excellent non-emergency intubating conditions in 2.5-3 minutes. The label gives no separate rapid sequence dose.
After intubation with succinylcholine: a lower first dose may be needed, 0.04-0.06 mg/kg with inhalation anesthesia or 0.05-0.06 mg/kg with balanced anesthesia.
Maintenance: 0.01-0.015 mg/kg IV. The first is usually needed 25-40 minutes after the intubating dose, then about every 12-15 minutes.
Pediatric dose
10-16 years: about the same mg/kg dose as adults.
1-10 years: may need a slightly higher first dose, and repeat doses slightly more often.
7 weeks to 1 year: more sensitive per mg/kg than adults, and take about 1.5 times as long to recover.
Under 7 weeks: no dose recommendation in the FDA label.
Route
IV
Special considerations
It has no effect on consciousness or pain. A paralyzed patient can still be awake and hurting, so give adequate sedation or anesthesia with it.
Use it only when intubation, ventilation, oxygen and reversal agents are immediately available, and be ready to assist or control breathing.
After an intubating dose, the block lasts about 25-30 minutes. Recovery to 95% takes about 45-65 minutes, and longer in cirrhosis or cholestasis.
Slow circulation (heart disease, old age, edema) can delay onset. Do not raise the dose to make up for it.
It comes as a powder in a 10 mg or 20 mg vial. The 10 mg vial made up to 10 mL, or the 20 mg vial made up to 20 mL, gives you 1 mg/mL either way.
Severe anaphylaxis has been reported. In myasthenia gravis, even small doses can have profound effects.
Follow your local protocols. Sources: FDA drug labels: Vecuronium bromide. Levels from the National EMS Scope of Practice Model (2019).